title: The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.
abstract: In this article we highlight the important role that medication therapy can play in preventing disease and controlling costs. Focusing on coronary artery disease, we demonstrate that prevention, with the appropriate use of generic medications, appears far more cost-effective than previously documented, and it may even save on costs. For example, an earlier study estimated that reducing blood pressure to widely established clinical guidelines in nondiabetic patients cost an estimated $52,983 per quality-adjusted life-year if a brand-name drug was used. However, we estimate that the cost is just $7,753 per quality-adjusted life-year at generic medication prices. As the nation attempts to find strategies to improve population health without adding to the unsustainably high cost of care, policy makers should focus on ensuring that patients have access to essential generic medications.
authors: CVS Caremark Harvard Partnership to Improve Medication Adherence, Brigham and Women's Hospital, Boston, MA, USA. wshrank@partners.org
authors: William H
authors: WH
authors: Shrank
authors: Niteesh K
authors: NK
authors: Choudhry
authors: Joshua N
authors: JN
authors: Liberman
authors: Troyen A
authors: TA
authors: Brennan
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control; D002908:Chronic Disease / Q000188:drug therapy / Q000517:prevention & control*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data*; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use; D005260:Female; D018166:Health Care Reform / Q000191:economics*; D006801:Humans; D008134:Long-Term Care / Q000191:economics; D008297:Male; D014481:United States
chemical_list: D016568:Drugs, Generic